Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Tim Beißbarth

From: From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Contact corresponding author